Is this you? Create Your Porfile
Avatar

Linda J. Bendall

Millennium Institute

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Linda J. Bendall is active.

Explore More

Publication

Featured researches published by Linda J. Bendall.

Blood | 2013

A Phase I/II Study Of Hyper-CVAD Plus Everolimus In Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Hagop M. Kantarjian; Deborah A. Thomas; Michael Rytting; Farhad Ravandi; Nitin Jain; Jorge Cortes; Rebecca Garris; Mary Ann Richie; Marina Konopleva; Hongbo Hu; Jitesh D. Kawedia; Kirk Culotta Pharmd; Susan O'Brien; Jordan Basnett; Lianchun Xiao; Xuelin Haung; Linda J. Bendall

Blood | 2010

S1P 1 Agonists for Use as Adjunct Mobilizing Agents

Nadia Harun; Marilyn Thien; Julius G Juarez; Kenneth F. Bradstock; Linda J. Bendall

Blood | 2007

The mTOR Inhibitor RAD001 (Everolimus) Improves Survival in Preclinical Models of Primary Human ALL.

Roman Crazzolara; Adam Cisterne; Marilyn Thien; John Hewson; Kenneth Francis Bradstock; Linda J. Bendall

Blood | 2011

Mobilizing agents G-CSF, cyclophosphamide or AMD3100 (Plerixafor) Have distinct effects on osteoblasts, hematopoietic stem cell niches, and B-Lymphopoiesis

Jean-Pierre Levesque; Linda J. Bendall; Allison R. Pettit; Liza J. Raggatt; Rebecca Jacobsen; Valarie Barbier; Bianca Nowlan; Yi Shen Shen; Natalie A. Sims; Ingrid G. Winkler

Blood | 2011

Sphingosine Kinase Inhibition Has Pre-Clinical Activity in Acute Lymphoblastic Leukemia,

Craig T. Wallington-Beddoe; David Ho; Kenneth F. Bradstock; Linda J. Bendall

Blood | 2011

Application of Dual PI-3K/mTOR Inhibitors Is Not Always Superior to Inhibition of mTOR Alone.,

Jacky Wong; Robert Welschinger; Rana Baraz; Kenneth F. Bradstock; Linda J. Bendall

Blood | 2010

ALL Cells Mobilized by AMD3100 Are More Proliferative, and Remain In the Circulation Longer Than Normal HSC, Enhancing the Action of Vincristine

Linda J. Bendall; Robert Welschinger; Florian Liedtke; Carole Ford; Aileen Dela Pena; Julius G Juarez; Kenneth F. Bradstock

Blood | 2005

The Wnt/β-Catenin Pathway Promotes Growth and Survival of Acute Lymphoblastic Leukaemia (ALL) Cells In Vitro.

Naveed I. Khan; Kenneth Francis Bradstock; Linda J. Bendall

Biology of Blood and Marrow Transplantation | 2018

Bone Marrow Graft-Versus-Host Disease in Reduced Intensity Conditioned Major Histocompatibility Complex Matched Murine Allogeneic Hematopoietic Cell Transplantation

Pablo A. Silveira; Kifah Shahin; Zamil Mattar; Wei Hsun Hsu; Linda J. Bendall; Derek N. J. Hart; Kenneth F. Bradstock

Archive | 2011

leukemia progenitors Growth requirements and immunophenotype of acute lymphoblastic

Dario Campana; Shotaro Iwamoto; Linda J. Bendall; Kenneth Francis Bradstock

Explore More

Collaboration

Dive into the Linda J. Bendall's collaboration.

Top Co-Authors
Avatar

Kenneth F. Bradstock

Westmead Hospital

View shared research outputs
Top Co-Authors
Avatar

Allison R. Pettit

University of Queensland

View shared research outputs
Top Co-Authors
Avatar

Jean-Pierre Levesque

University of Queensland

View shared research outputs
Top Co-Authors
Avatar

Liza J. Raggatt

University of Queensland

View shared research outputs
Top Co-Authors
Avatar

Natalie A. Sims

St. Vincent's Institute of Medical Research

View shared research outputs
Top Co-Authors
Avatar

Bianca Nowlan

University of Queensland

View shared research outputs
Top Co-Authors
Avatar

Craig T. Wallington-Beddoe

University of Sydney

View shared research outputs
Top Co-Authors
Avatar

David Ho

University of Sydney

View shared research outputs
Top Co-Authors
Avatar

Derek N. J. Hart

University of Sydney

View shared research outputs
Top Co-Authors
Avatar

Falak Helwani

Translational Research Institute

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge